Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
复制标题
DOI:
10.1053/j.gastro.2010.04.010
复制
发表时间:
2010-07
期刊:
影响因子:
29.4
通讯作者:
LaRusso NF
中科院分区:
文献类型:
--
作者:
Gradilone SA;Masyuk TV;Huang BQ;Banales JM;Lehmann GL;Radtke BN;Stroope A;Masyuk AI;Splinter PL;LaRusso NF
In polycystic liver diseases, cyst formation involves cholangiocyte hyperproliferation. In PCK rats, an animal model of autosomal recessive polycystic kidney disease (ARPKD), decreased [Ca2+]i in cholangiocytes is associated with hyperproliferation. We recently showed Trpv4, a calcium-entry channel, is expressed in normal cholangiocytes and its activation leads to [Ca2+]i increase. Thus, we hypothesized that pharmacological activation of Trpv4 might reverse the hyperproliferative phenotype of PCK cholangiocytes. Trpv4 expression was examined in liver of normal and PCK rats, normal humans, and patients with autosomal dominant PKD (ADPKD) or ARPKD. Trpv4 activation effect on cell proliferation and cyst formation was assessed in cholangiocytes derived from normal and PCK rats. The in vivo effects of Trpv4 activation on kidney and liver cysts was analyzed in PCK rats. Trpv4 was overexpressed both at mRNA (8-fold), and protein (3-fold) levels in PCK-cholangiocytes. Confocal and immunogold electron-microscopy supported Trpv4 overexpression in the livers of PCK rats and ARPKD or ADPKD patients. Trpv4 activation in PCK cholangiocytes increased [Ca2+]i by 30% inhibiting cell proliferation by ~25-50% and cyst growth in 3-D-culture (3-fold). Trpv4-siRNA-silencing blocked effects of Trpv4 activators by 70%. Trpv4 activation was associated with Akt phosphorylation and β-Raf and Erk1/2 inhibition. In vivo, Trpv4 activation induced a significant decrease in renal cystic area and a non significant decrease in liver cysts. Taken together, our in vitro and in vivo data, suggest that increasing intracellular calcium by Trpv4 activation may represent a potential therapeutic approach in PKD.
登录
查看更多内容
影响因子:
6
作者:
Banales, Jesus M.;Masyuk, Tatyana V.;LaRusso, Nicholas F.
通讯作者:
LaRusso, Nicholas F.
影响因子:
5.3
作者:
Alessandri-Haber, N;Dina, OA;Levine, JD
通讯作者:
Levine, JD
影响因子:
13.6
作者:
Gattone, Vincent H., II;Chen, Neal X.;Moe, Sharon M.
通讯作者:
Moe, Sharon M.
DOI:
10.1073/pnas.0700499104
发表时间:
2007-03-13
影响因子:
11.1
作者:
Leuenroth, Stephanie J.;Okuhara, Dayne;Crews, Craig M.
通讯作者:
Crews, Craig M.
影响因子:
7.8
作者:
Koetttgen, Michael;Buchholz, Bjoern;Garcia-Gonzalez, Miguel A.;Kotsis, Fruzsina;Fu, Xiao;Doerken, Mara;Boehlke, Christopher;Steffl, Daniel;Tauber, Robert;Wegierski, Tomasz;Nitschke, Roland;Suzuki, Makoto;Kramer-Zucker, Albrecht;Germino, Gregory G.;Watnick, Terry;Prenen, Jean;Nilius, Bernd;Kuehn, E. Wolfgang;Walz, Gerd
通讯作者:
Walz, Gerd